A Potential Role of B7-H4 Expression in Predicting the Recurrence of Chronic Rhinosinusitis with Nasal Polyps.

Background: Chronic rhinosinusitis with polyps (CRSwNP) is a common chronic inflammatory disease of the nasal cavity and sinuses with a high rate of postoperative recurrence. In this study, we aim to investigate the expression of B7-H4 in CRSwNP and its association with postoperative recurrence.
Methods: A total of 80 CRSwNP patients, including 40 primary CRSwNP (pCRSwNP) patients and 40 recurrent CRSwNP (rCRSwNP) patients, 27 chronic rhinosinusitis without polyps (CRSsNP) and 32 healthy controls (HC) were enrolled in this study, and the serum, nasal polyps and middle turbinate tissue samples were collected. Peripheral and tissue B7-H4 expressions were detected by enzyme-linked immunosorbent assay (ELISA) and reverse transcription-polymerase chain reaction (RT-PCR) and immunofluorescence, and their clinical values in predicting postoperative recurrence of CRSwNP were evaluated.
Results: We identified significantly higher tissue B7-H4 mRNA levels in the CRSwNP group than in the HC group, and elevated B7-H4 levels were associated with tissue eosinophil count and percentage (r = 0.469, P < 0.001; r = 0.521, P < 0.001). B7-H4 mRNA and protein levels were significantly higher in the rCRSwNP group than the pCRSwP group. Multivariate analysis and receiver operating characteristic (ROC) curves showed that tissue B7-H4 levels were associated with postoperative recurrence in patients with CRSwNP (P < 0.05). In addition, serum B7-H4 levels were significantly increased in the CRSwNP group than the CRS and HC groups, especially in the rCRSwNP group (P < 0.05), and the ROC curve presented a predictive ability of serum B7-H4 in predicting postoperative recurrence.
Conclusion: Our results indicated that B7-H4 level was clearly enhanced in CRSwNP patients and associated with postoperative recurrence. Serum B7-H4 might serve as a simple and convenient biomarker for early predicting postoperative recurrence in CRwNP patients.

Introduction

Chronic rhinosinusitis (CRS) is a heterogeneous disease of the upper respiratory tract with chronic inflammation in nasal and paranasal sinuses mucosa persisting for at least 12 weeks.1 The common symptoms of CRS include nasal obstruction, drainage, smell loss, and facial pain or pressure.2 CRS is frequently further divided into two subtypes: CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP) based on the presence of nasal polyps.3–6 Previous studies have shown that CRSwNP was characterized by T helper 2 (Th2)-dominant inflammation and tissue eosinophils infiltration, which resulted in serious disease symptoms, poorer prognosis, and high recurrence rate of postoperative.7,8 Recently, macrophages have been observed in nasal polyps, and the accumulation of mannose-receptor positive macrophages (M2 macrophages) was identified in nasal polyps in cell aggregates which suggests that they play a key role in the pathogen-macrophage interaction in CRSwNP.9 Although medical treatment and nasal endoscopic surgery were the mainstream treatment in CRSwNP, there remains a large number of patients still suffer from relapse. Meng et al followed up 230 CRSwNP patients for more than 24 months after surgery, and they found that 51.3% of them were recurrent.10 Moreover, other publications reported that the short-term recurrence rates of CRSwNP ranged from 21% to 66%.11 Considering that the disease has a higher rate of recurrence, there is an urgent need to explore biomarkers for early prediction of nasal polyp recurrence, which may contribute to developing treatment strategies, adjusting follow-up protocols, and achieving precision treatment.

B7-H4, also known as B7S1, B7x, VTCN1, is widely expressed on most antigen-presenting cells (APCs) including dendritic cells, peritoneal macrophages, and splenic B cells.12,13 Moreover, B7-H4 is also the cell surface marker of M2 macrophages and crucial in maintaining the function of macrophages.14 Previous studies have shown that B7-H4 acts an essential role in tumor, organ transplantation rejection, inflammatory and autoimmune diseases.14–18 A recent publication found that serum B7-H4 levels were elevated with disease progression in allergic and autoimmune diseases mediated by T helper 1 (Th1) or Th2 cell activation.19 In addition, previous studies found that B7 promoted IL-10 production, which could enhances the migration of eosinophils.20,21 Given that, we speculate that B7-H4 may be involved in the pathophysiology of CRSwNP and contribute to its postoperative recurrence. Therefore, the present study aims to explore the role of B7-H4 in CRSwNP and clinical value as an objective marker to predict postoperative recurrence via detecting its tissue and serum expression levels in CRSwNP patients.

Materials and Methods

Participants and Settings

We recruited 32 health controls (HC) and 27 CRSsNP patients, and 80 CRSwNP patients including 40 primary CRSwNP (pCRSwNP) and 40 recurrent CRSwNP (rCRSwNP) who were treated in our hospital between October 2020 and June 2021. Diagnosis of CRSwNP and CRSsNP was strictly confirmed according to the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS).22 Recurrent CRSwNP is defined as: despite the rescue plan of antibiotics and oral steroids during follow-up, there are still typical symptoms, endoscopic images and/or computed tomography (CT) scan evidence were obtained during outpatient clinic follow-up as previously described.10,23,24 None of the patients were treated with glucocorticoids, immunomodulatory agents, or antibiotics within 4 weeks before enrollment. Patients with fungal sinusitis, allergic fungal rhinosinusitis, cystic fibrosis, or primary ciliary dyskinesia were excluded. Age and sex-matched health controls without nasal or sinus inflammatory diseases were similarly recruited as control group. This study was approved by the Institutional Review Board of Xiangya Hospital. Informed consent was obtained from the patients enrolled.

RNA Extraction, Reverse Transcription and Quantitative Realtime Polymerase Chain Reaction (qRT-PCR) Amplification

Middle turbinate mucosa for CRSsNP patients and HCs, and nasal polyp specimens from CRSwNP patients were collected during functional endoscopic sinus surgery and immediately snap-frozen in liquid nitrogen. Total RNA in tissue sample was extracted by the Trizol® method following the manufacturer’s instructions. The quality of total RNA was assessed with the Nanodrop-2000 (Thermo Fisher Scientific, Waltham, MA, USA). Single-strand cDNA was synthesized with PrimeScript™ RT Master Mix (US EVERBRIGHT, Suzhou, China), and aliquots of cDNA equivalent to 10 ng of total RNA in each well were used for qRT-PCR. The qRT-PCR was performed as described previously.25 Briefly, qRT-PCR was performed using 10 ng of cDNA with the SYBR Green qPCR Supermix (US EVERBRIGHT, Suzhou, China) to monitor DNA synthesis using specific primers. The mRNA expression of gene was calculated using the comparative threshold cycle (2−ΔΔCT) method. GAPDH was used as the control and the primers used for amplifying GAPDH and B7-H4 were displayed in .

Immunofluorescence Staining

Collected tissue specimens were fixed 4% paraformaldehyde, embedded with paraffin, sectioned into 5-μm sections by microtome. The tissue sections were first stained with primary antibody to B7-H4 (Affinity Biosciences, Changzhou, China) overnight at 4°C. After washing, the tissue sections were incubated with Alexa Fluor 594–conjugated secondary antibodies at room temperature for 2 hours.26 The numbers of positive cells of each type in the lamina propria per high-power field (HPF) were counted, as previously described.27 Histological changes and B7-H4 expressions in the sections were observed by two independent pathologists and the presentative images were selected and displayed in the Results Section.

Enzyme-Linked Immunosorbent Assay (ELISA)

In order to detect the serum B7-H4 concentrations in all subjects, we conducted ELISA.

Five mL fasting blood was collected from each participant with vacuum blood collection tubes. Harvested samples were coagulated at room temperature for 1 h and centrifuged at 3000 rpm for 10 min at 4°C, then, the supernatant was collected and stored for subsequent test. Serum B7-H4 levels were quantified by ELISA kit (CUSABIO, Wuhan, China) referring to the manufacturer’s instructions. Operator was blinded to the clinical data of patients.

Statistical Analysis

All data were expressed as the mean± standard deviation. One-way analysis of variance (ANOVA) or Student’s t-test was conducted when the variables distributed normally, otherwise, Kruskal–Wallis H-test or Mann–Whitney U-test was performed. Correlations between mRNA level of B7-H4 and clinical variables were assessed by Spearman’s rank correlation analysis. Multivariate analysis and receiver operating characteristic (ROC) curves were performed to identify predictive factors associated with polyp recurrence and determine the predictive values of special parameters, based on the area under the curves (AUCs) for a particular characteristic. Statistical analyses were performed with SPSS statistics software version 25.0 (IBM, Chicago, IL, USA). A P value < 0.05 was defined as statistically significant.

Results

Demographics of the Study Subjects

Demographic and clinical data are shown in Table 1. Results indicated that the rate of allergic rhinitis, peripheral eosinophil count and percentage were significantly increased in CRSwNP group than the other two groups (all P < 0.05). The VAS score and Lund-Mackay score were higher in CRSwNP group than CRSsNP group (all P < 0.001). No significant difference was found in sex, age, BMI among three groups. As shown in Table 2, the patients in the recurrent group had significantly higher rate of allergic rhinitis, peripheral eosinophil count and percentage, and VAS score than in the primary group (all P < 0.05), and no statistical difference was observed between two groups for the other variables.

Table 1

The Demographic and Clinical Characteristics Among Three Groups

Variables	HC (n=32)	CRSsNP (n=27)	CRSwNP (n=80)	P-value
Age, years	40.9±13.2	37.9±14.6	43.5±13.2	0.167
Gender (male/female)	19/13	14/13	42/38	0.781
BMI, kg/m2	23.0±3.1	23.5±3.1	24.4±3.5	0.085
Allergic rhinitis (yes/no)	0/32	8/19	26/54	0.001
Asthma (yes/no)	0/32	2/25	12/68	0.051
Peripheral eosinophil count, 109/L	0.05±0.03	0.09±0.06	0.27±0.11	<0.001
Peripheral eosinophil percentage, %	0.6±0.3	0.1±0.0	5.1±2.2	<0.001
VAS score	–	4.9±1.6	6.8±1.8	<0.001
Lund-Mackay score	–	12.0±2.5	17.4±3.0	<0.001

Abbreviations: HC, healthy control; CRSsNP, chronic rhinosinusitis without nasal polyps; CRSwNP, chronic rhinosinusitis with nasal polyps; BMI, body mass index; VAS, visual analogue scale. Bold font indicates statistical difference.

Table 2

The Demographic and Clinical Parameters Between pCRSwNP Group and rCRSwNP

Variables	pCRSwNP Group (n=35)	r CRSwNP Group (n=34)	P-value
Age, years	43.7±12.5	43.3±14.0	0.907
Gender (male/female)	25/15	22/18	0.051
BMI, kg/m2	25.2±3.5	23.7±3.3	0.597
Allergic rhinitis (yes/no)	4/36	14/26	0.014
Asthma (yes/no)	3/37	7/33	0.311
Peripheral eosinophil count, 109/L	0.3±0.1	0.3±0.1	0.379
Peripheral eosinophil percentage, %	4.7±1.8	5.4±2.6	0.187
Tissue eosinophil count, 109/L	18.8±12.5	32.4±24.2	0.003
Tissue eosinophil percentage, %	11.6±7.7	16.8±10.9	0.016
VAS score	6.6±1.7	7.1±1.9	0.209
Lund-Mackay score	17.9±3.2	16.9±2.8	0.141
Serum B7-H4 level	3.6±0.8	4.7±0.8	< 0.001
Tissue B7-H4 mRNA level	1.0±0.5	1.7±0.6	< 0.001

Abbreviations: pCRSwNP, primary chronic rhinosinusitis with nasal polyps; rCRSwNP, recurrent chronic rhinosinusitis with nasal polyps; BMI, body mass index; VAS, visual analogue scale. Bold font indicates statistical difference.

B7-H4 Expression Level in Nasal Tissues and Its Correlation with Clinical Variables

As exhibited in Figure 1A, the average tissue B7-H4 mRNA expression levels were significantly higher in the CRSwNP group than CRSsNP group and HC group, but no statistic difference was observed between CRSsNP group and HC group. CRSwNP group were further divided into CRSwNP with allergic rhinitis (AR) group and CRSwNP without AR group, and CRSwNP with asthma (AS) group and CRSwNP without AS group based on the comorbidity. The expression levels of B7-H4 were not statistically different between these subgroups (Figure 1B and C). The Spearman correlation results in Figure 2 showed that tissue B7-H4 levels were positively correlated with tissue eosinophil count (r = 0.469, P < 0.001) and tissue eosinophil percentage (r = 0.521, P < 0.001), respectively. The relative B7-H4 mRNA levels were significantly higher in tissue from rCRSwNP patients than pCRSwNP patients (P < 0.001, Figure 3A). Logistic regression analysis results demonstrated that tissue B7-H4 mRNA levels were associated with CRSwNP postoperative recurrence (Table 3). ROC curve in Figure 3B showed that tissue B7-H4 mRNA level presented a potential ability in predicting CRSwNP postoperative recurrence (AUC = 0.788, P < 0.001).

Figure 1

Comparison of tissue B7-H4 mRNA levels among CRSwNP, CRS and HC groups. (A) Tissue B7-H4 mRNA levels were increased in the CRSwNP group than the CRS and HC groups. (B) The expression levels of B7-H4 in the CRSwNP with AR group and CRSwNP without AR group. (C) Compared to CRSwNP without AS group, B7-H4 levels were also no significantly difference in the CRSwNP with AS group. *P<0.05, **P<0.01.

Figure 2

The associations between tissue B7-H4 levels and clinical variables (A-H) in CRSwNP patients. Elevated B4-H4 mRNA levels exhibited positively correlation with tissue eosinophil count and percentage (G and H).

Figure 3

Comparison of tissue B7-H4 mRNA levels between two. (A) Tissue B7-H4 expression levels were higher in the rCRSwNP group than the pCRSwNP group. (B) ROC curve analysis of tissue B7-H4 in predicting CRSwNP recurrence. ****P < 0.0001.

Table 3

Logistic Regression Analysis of Factors Associated with the Rate of Recurrence in CRSwNP Patients

Variables	OR	95% CI	P-value
Allergic rhinitis	0.393	0.149–1.038	0.059
Peripheral eosinophil count, 109/L	0.155	0.003–9.427	0.374
Peripheral eosinophil percentage, %	1.148	0.935–1.409	0.187
Tissue eosinophil count, 109/L	1.048	1.014–1.083	0.005
Tissue eosinophil percentage, %	1.064	1.009–1.121	0.021
Serum B7-H4 level	6.837	2.808–16.649	< 0.001
Tissue B7-H4 mRNA level	7.674	2.794–21.078	< 0.001

Abbreviations: CRSwNP, chronic rhinosinusitis with nasal polyps; Bold font indicates statistical difference.

Immunofluorescence Staining for B7-H4

As indicated by representative immunofluorescence staining images (Figure 3), the B7-H4 protein expression level was significantly elevated in the CRSwNP group in comparison with HC and CRSsNP groups, and markedly enhanced in the rCRSwNP group than pCRSwNP group (Figure 4). B7-H4 staining was mainly located in the nasal epithelial cells and submucosa areas, and the number of B7-H4+ positive cells was increased in CRSwNP group in comparison with HC and CRSsNP groups (Figure 5), and increased number of B7-H4+ positive cells was also found in recurrent group than primary group (Figure 6).

Figure 4

Immunofluorescence and B7-H4 protein expression in the tissue among three groups. Representative immunofluorescence images of HC, CRSsNP and CRSwNP (magnification x400).

Figure 5

Immunofluorescence and B7-H4 protein expression in primary and recurrent CRSwNP patients. Representative immunofluorescence images of pCRSwNP and rCRSwNP patients (magnification, x400).

Figure 6

Quantification of B7-H4+ cells in immunofluorescence staining. (A) Compared to, the increased the number of B7-H4+ cell in the CRSwNP group was higher the CRSsNP and HC groups. (B) The B7-H4+ cell number were significantly higher in the rCRSwNP group than the pCRSwNP group. **P<0.01; ***P<0.001; ****P<0.0001.

Serum B7-H4 Concentrations in CRSwNP

Serological results highlighted that B7-H4 concentrations were significantly elevated in the CRSwNP group than CRSsNP and HC group, and the serum B7-H4 concentrations were significantly enhanced in the rCRSwNP group than pCRSwNP group (P < 0.05, Figure 7A and B). Binary logistic regression analysis results in Table 3 demonstrates that serum B7-H4 level (OR = 6.837, P < 0.001) was associated with CRSwNP postoperative recurrence. ROC curves showed that serum B7-H4 (AUC = 0.852) presented potential value in predicting postoperative recurrence (Figure 7C). Intriguingly, the Spearman correlation results showed that serum B7-H4 concentrations positively correlated with the B7-H4 mRNA expression levels in nasal polyps in CRSwNP patients (r = 0.470, P < 0.001) ().

Figure 7

Differential expressions of serum B7-H4 concentrations in different groups. (A) Serum B7-H4 concentrations were increased in the CRSwNP group than the CRSsNP and HC groups. (B) Serum B7-H4 concentrations in the rCRSwNP group were higher than the pCRSwNP group. (C) ROC curve analysis of serum B7-H4 in predicting CRSwNP recurrence. **P<0.01; ***P<0.001; ****P<0.0001.

Discussion

In the present study, our results showed that tissue B7-H4 levels were significantly enhanced in the CRSwNP group, especially in the rCRSwNP patients, and elevated B7-H4 levels were positively with the degree of tissue eosinophil infiltration. Statistical analysis results showed that tissue B7-H4 levels were closely linked with CRSwNP recurrence. Moreover, serological results were consistent with the above findings, and binary logistic regression and ROC curve analysis demonstrated that circulating B7-H4 levels were associated with CRSwNP recurrence. Based on these results, we believe that B7-H4 may be involved in the pathogenesis of CRSwNP, and promote its recurrence after surgery. Therefore, tissue and serum B7-H4 level may serve as potential biomarkers for predicting postoperative recurrence in CRwNP patients.

Macrophages are important members of innate immune cells which participate in adaptive immunity,28 and their phenotype and functions are affected by the surrounding micro-environment.29 Previous studies have shown that classically activated (M1) and alternatively activated (M2) macrophages are two major macrophage sub-populations, and they exhibited different biological functions and are involved in the occurrence and development of various diseases.30,31 Accordingly, M1 macrophages are typically induced by Th1 cytokines, such as IFN-γ and TNF-α, while M2 macrophages are polarized by Th2 cytokines and exhibit anti-inflammatory effects.32–35 It has been proven that CRSwNP is characterized by Th2-related inflammation, and M2 macrophages serve crucial roles in promoting Th2 inflammation response and are closely involved in pathological mechanisms of CRSwNP. Recent studies observed that the number of M2 macrophages but not M1 macrophages were significantly increased in the peripheral blood and tissue of CRSwNP patients.36,37 B7-H4, as an important cell surface marker of M2 macrophages, may be involved in the occurrence and development of chronic inflammatory diseases, including CRSwNP. Xiao et al38 found that the concentration of soluble B7-H4 was significantly higher in patients with systemic lupus erythematosus and lupus nephritis in comparison with healthy subjects, and the elevated B7-H4 levels correlated with the disease severity. In another study, Chen et al39 found that B7-H4 was expressed in CD34(+) endothelial cells of neovessels in rheumatoid synovium, which suggested that B7-H4 was involved in the pathological changes of rheumatoid synovium in rheumatoid arthritis. In this study, we observed that tissue B7-H4 mRNA and protein expression levels were elevated in the CRSwNP group in comparison with the HC and CRSsNP groups, and B7-H4 mRNA levels were associated with tissue eosinophilia. Prior studies found that tissue eosinophil infiltration plays an important role in the occurrence and progression of CRSwNP, and M2 macrophages could promote eosinophil migration via secreting chemokines, such as C-C motif chemokine ligand 17 (CCL17), CCL18, CCL22, and CCL24.40,41 Therefore, we speculated that B7-H4 might activate M2 macrophages, then triggered Th2 inflammatory response and eosinophils recruitment, resulting in excessively inflammatory conditions in CRSwNP.

Currently, although functional endoscopic sinus surgery and pharmaceutical treatment improve the quality of life in CRSwNP patients, a large portion of patients still suffered a high rate of recurrence, especially in those with tissue eosinophilia. Therefore, exploring risk factors associated with CRSwNP recurrence and predicting its early recurrence are urgently needed for rhinologists. Previous publications showed that tissue and peripheral eosinophil count and percentage were associated with the relapse of CRSwNP, but their predictive abilities for postoperative recurrence needed further validation.42,43 In this study, we firstly demonstrated that soluble and membrane-bound forms of B7-H4 expression levels were significantly elevated in rCRSwNP patients, and were closely linked with the rate of CRSwNP postoperative recurrence. Moreover, binary logistic regression and ROC curve analyses demonstrated that both forms of B7-H4 presented promising values for predicting CRSwNP recurrence. Growing evidence suggested that Th2 inflammation and eosinophilic inflammation were vital endotypes associated with poorly-controlled disease and recurrence in patients with CRSwNP.42,44 A recent study showed that serum B7-H4 levels were elevated with disease progression in allergic and autoimmune diseases.19 Another prior study found that serum B7-H4 levels were enhanced in the ovalbumin (OVA) induced animal models and associated with the concentrations of Th2 cytokines, which suggested that B7-H4 might be a key promoter for allergic inflammation.19 In the present study, our results highlighted that tissue eosinophil count and percentage were raised in CRSwNP patients and were related with the postoperative recurrence, which was in accordance with prior studies. Besides, tissue and serum B7-H4 expression levels were clearly elevated in the rCRSwNP group than the pCRSwNP group, and the tissue B7-H4 levels were positively correlated with tissue eosinophil count and percentage, which suggested that B7-H4 might facilitate eosinophilia and be emerged in the recurrence CRSwNP. All above findings suggested that serum and tissue B7-H4 might serve as potential clinical biomarkers for preoperatively predicting CRSwNP recurrence.

There are several limitations in our study. First, the sample size of participants included in the study was relatively small, making the statistical analysis challenging. Second, we did not conduct a validation cohort to strengthen the results in this study. Finally, we did not analyze the correlation between the B7-H4 expression level and the severity of the disease. Further multicenter studies with a larger sample size are needed to confirm the results of this study and explore the accuracy mechanisms of B7-H4 in CRSwNP.

In conclusion, we confirmed the association between B7-H4 and CRSwNP in the present study. We firstly demonstrated that both soluble and membrane-bound forms of B7-H4 were overexpressed in CRSwNP and associated with postoperative recurrence. Serum B7-H4 might serve as a simple and convenient biomarker for early predicting postoperative recurrence in CRSwNP patients.